You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

APOE E4; cognition; metabolic markers; beta-amyloid

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Alzheimer's Disease; Dementia Trial in Seattle (HIGH and LOW meal ingestion)

Recruiting
  • Alzheimer's Disease; Dementia
  • HIGH and LOW meal ingestion
  • Seattle, Washington
    University of Washington Medical Center
Nov 10, 2022

l Disturbances of Spatial Cognition

Recruiting
  • Spatial Navigation
  • Virtual and computer-based cognitive remediation training
  • Milano, Lombardy, Italy
    Istituto Auxologico Italiano
Jul 19, 2023

Mild Cognitive Impairment, Insulin Resistance, Diabetes, Type 2 Trial in Singapore (Metformin, Intensive Lifestyle Intervention,

Terminated
  • Mild Cognitive Impairment
  • +2 more
  • Singapore, Singapore
    SingHealth Polyclinics - Marine Parade Polyclinic
Jan 9, 2023

Alzheimer's Disease Treatment With Combination of 40Hz Light and

Recruiting
  • Alzheimer Disease
  • +5 more
  • Combination of 40Hz light and cognitive therapy (ALZLIFE)
  • Miami, Florida
    Andrey Vyshedskiy
Jan 31, 2023

Alzheimer Trial in Auburn (Extra virgin olive oil)

Not yet recruiting
  • Alzheimer Disease
  • Extra virgin olive oil
  • Auburn, Alabama
    Auburn University
Jul 1, 2023

Database to Investigate Blood-Based and Digital Biomarkers in

Recruiting
  • Alzheimer Disease
  • +5 more
  • Biomarker Data Collection
  • Aventura, Florida
  • +15 more
Sep 21, 2022

Alzheimers Disease Trial in Worldwide (CNP520 50mg, CNP520 15mg, Matching )

Terminated
Has Results
  • Alzheimers Disease
  • CNP520 50mg
  • +2 more
  • Phoenix, Arizona
  • +193 more
Aug 4, 2021

Alzheimer, Mild Cognitive Impairment, Metabolic Syndrome Trial in Ramat Gan (Semaglutide, Intranasal insulin, Semaglutide )

Not yet recruiting
  • Alzheimer Disease
  • +2 more
  • Ramat Gan, Israel
    Joseph Sagol Neuroscience center, Sheba Medical Center
Oct 3, 2023

Vanderbilt Memory and Aging Project

Recruiting
  • Alzheimer Disease
  • +7 more
  • none, observational study
  • Nashville, Tennessee
    Vanderbilt University Medical Center
May 11, 2022

Postoperative Cognitive Dysfunction Trial in San Francisco (Florbetapir F 18 (18F-AV-45), no intervention)

Recruiting
  • Postoperative Cognitive Dysfunction
  • Florbetapir F 18 (18F-AV-45)
  • no intervention
  • San Francisco, California
    San Francisco VA Medical Center
Jul 6, 2021

Metabolic Diseases, Aging Problems Trial in Kelowna (Fed, Fasted)

Not yet recruiting
  • Metabolic Diseases
  • Aging Problems
  • Fed
  • Fasted
  • Kelowna, British Columbia, Canada
    University of British Columbia - Okanagan Campus
Aug 22, 2023

Alzheimer, Late Onset, Mild Cognitive Impairment, Sleep Trial in Pittsburgh (Time in Bed Restriction, Sleep Schedule)

Recruiting
  • Alzheimer Disease, Late Onset
  • +4 more
  • Time in Bed Restriction
  • Sleep Schedule
  • Pittsburgh, Pennsylvania
    UPMC Western Psychiatric Hospital
Oct 25, 2022

Mild Cognitive Impairment(MCI), Alzheimer, Late Onset, Familial Alzheimer (FAD) Trial in China

Recruiting
  • Mild Cognitive Impairment(MCI)
  • +5 more
    • Hefei, Anhui, China
    • +64 more
    Jan 2, 2023

    Insomnia Trial in Kansas City (Cognitive Behavioral Therapy for Insomnia (CBT-I), Sleep and Lifestyle Education)

    Recruiting
    • Insomnia
    • Cognitive Behavioral Therapy for Insomnia (CBT-I)
    • Sleep and Lifestyle Education
    • Kansas City, Kansas
      University of Kansas Medical Center- Sleep, Health and Wellness
    Nov 1, 2022

    Artificial Intelligence-based Computer Aided Diagnosis Software

    Completed
    • Alzheimer Disease
    • Mild Cognitive Impairment
    • NeuroAI
    • Gwangju, Korea, Republic of
      Chonnam National University Hospital
    Sep 14, 2022

    Cerebral Amyloid Angiopathy, Intracranial Hemorrhages, Alzheimer Trial in Taipei (1. amyloid PET;2. T807 PET)

    Recruiting
    • Cerebral Amyloid Angiopathy
    • +2 more
    • 1. amyloid PET；2. T807 PET
    • Taipei, Taiwan
      National Taiwan Univeristy Hospital
    Mar 10, 2021

    PreDiabetes, Hyperglycemia Trial in Nottingham, Birmingham (Beta-alanine, Placebo)

    Recruiting
    • Prediabetes
    • +2 more
    • Beta-alanine
    • Placebo
    • Nottingham, Nottinghamshire, United Kingdom
    • +1 more
    Dec 19, 2022

    Multiple Sclerosis Trial in Pavia (18F-florbetaben PET/CT)

    Recruiting
    • Multiple Sclerosis
    • 18F-florbetaben PET/CT
    • Pavia, PV, Italy
      ICS Maugeri SpA SB IRCCS
    Mar 23, 2023

    Alzheimer, Cognitive Decline Trial in Dallas ([18F]AV-1451, Positron Emission Tomography)

    Completed
    • Alzheimer Disease
    • Cognitive Decline
    • Dallas, Texas
      UT Southwestern Medical Center
    Jul 28, 2022

    Alzheimer's Disease Trial in New York (11C-PBR28, 18F-Florbetaben, Lumbar puncture (optional))

    Enrolling by invitation
    • Alzheimer's Disease
    • New York, New York
      Columbia University Medical Center
    Aug 4, 2021

    Hypertension Trial in Dallas (Standard Care, Intensive Treatment)

    Active, not recruiting
    • Hypertension
    • Standard Care
    • Intensive Treatment
    • Dallas, Texas
      UT Southwestern Medical Center
    Aug 11, 2022

    Alzheimer, Early Onset Trial in Paris (Ketogenic diet)

    Not yet recruiting
    • Alzheimer Disease, Early Onset
    • Ketogenic diet
    • Paris, France
      Cognitive Neurology Center - Lariboisière Fernand Widal Universi
    Nov 22, 2021

    Alzheimer Trial in Santa Monica (NE3107)

    Completed
    • Alzheimer Disease
    • Santa Monica, California
      Neurological Associates - The Interventional Group
    Sep 26, 2022

    Cognitively Normal Older Adults, Hypertension, Subjective Cognitive Decline Trial in Dallas (Angiotensin II Receptor Blockers

    Recruiting
    • Cognitively Normal Older Adults
    • +3 more
    • Angiotensin II Receptor Blockers (ARBs, losartan) and Calcium Channel Blockers (CCB, amlodipine)
    • PCP
    • Dallas, Texas
      University of Texas Southwestern Medical Center
    Dec 1, 2022

    Alzheimer Trial in New York (LX1001)

    Not yet recruiting
    • Alzheimer Disease
    • LX1001
    • New York, New York
      Weill Cornell Medicine
    Oct 13, 2022